These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 39137049
1. Navigating Renin-Angiotensin System Inhibitors in Patients with Declines in eGFR. Shulman R, Cohen JB. J Am Soc Nephrol; 2024 Oct 01; 35(10):1309-1311. PubMed ID: 39137049 [No Abstract] [Full Text] [Related]
2. Inhibition of the renin-angiotensin-aldosterone system: how to obtain this. Pende A, Montecucco F. Curr Pharm Des; 2012 Oct 01; 18(7):950-1. PubMed ID: 22283769 [No Abstract] [Full Text] [Related]
3. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. N Engl J Med; 2020 Apr 23; 382(17):1653-1659. PubMed ID: 32227760 [No Abstract] [Full Text] [Related]
4. How should we modify recommended renin-angiotensin-aldosterone system inhibition when facing the cardiorenal syndrome? Sexton DJ. Circ Heart Fail; 2014 May 23; 7(3):536. PubMed ID: 24847129 [No Abstract] [Full Text] [Related]
5. Addition of vitamin D reverses the decline in GFR following treatment with ACE inhibitors/angiotensin receptor blockers in patients with chronic kidney disease. Soares AE, Maes M, Godeny P, Matsumoto AK, Barbosa DS, da Silva TAF, Souza FHMO, Delfino VDA. Life Sci; 2017 Dec 15; 191():175-179. PubMed ID: 29079468 [Abstract] [Full Text] [Related]
6. Renin-Angiotensin System Inhibition in Advanced Chronic Kidney Disease. Bhandari S, Mehta S, Khwaja A, Cleland JGF, Ives N, Brettell E, Chadburn M, Cockwell P, STOP ACEi Trial Investigators. N Engl J Med; 2022 Dec 01; 387(22):2021-2032. PubMed ID: 36326117 [Abstract] [Full Text] [Related]
7. Role of renin-angiotensin system blockade in advanced CKD: to use or not to use? Mukoyama M, Kuwabara T. Hypertens Res; 2022 Jun 01; 45(6):1072-1075. PubMed ID: 35361929 [No Abstract] [Full Text] [Related]
13. Association between Acute Declines in eGFR during Renin-Angiotensin System Inhibition and Risk of Adverse Outcomes. Ku E, Tighiouart H, McCulloch CE, Inker LA, Adingwupu OM, Greene T, Estacio RO, Woodward M, de Zeeuw D, Lewis JB, Hannedouche T, Hou FF, Jafar TH, Imai E, Remuzzi G, Heerspink HJL, Toto RD, Sarnak MJ. J Am Soc Nephrol; 2024 Oct 01; 35(10):1402-1411. PubMed ID: 38889197 [Abstract] [Full Text] [Related]
15. Blockers of the renin-angiotensin-aldosterone system: almost, but not yet, an absolute weapon against cardiovascular and renal diseases! Waeber B. J Renin Angiotensin Aldosterone Syst; 2012 Mar 01; 13(1):216. PubMed ID: 22389390 [No Abstract] [Full Text] [Related]
16. Estimated Effect of Restarting Renin-Angiotensin System Inhibitors after Discontinuation on Kidney Outcomes and Mortality. Hattori K, Sakaguchi Y, Oka T, Asahina Y, Kawaoka T, Doi Y, Hashimoto N, Kusunoki Y, Yamamoto S, Yamato M, Yamamoto R, Matsui I, Mizui M, Kaimori JY, Isaka Y. J Am Soc Nephrol; 2024 Oct 01; 35(10):1391-1401. PubMed ID: 38889205 [Abstract] [Full Text] [Related]
17. Lower blood pressure target in nondiabetic proteinuric chronic kidney disease is not justified. McCormick BB, Hiremath S, Ruzicka M. Kidney Int; 2014 Oct 01; 86(4):855. PubMed ID: 25265952 [No Abstract] [Full Text] [Related]
18. An ACE in the hole for patients with advanced chronic kidney disease? Park M, Hsu CY. JAMA Intern Med; 2014 Mar 01; 174(3):355-6. PubMed ID: 24342932 [No Abstract] [Full Text] [Related]
19. Renin-Angiotensin System Modulation in Adults With COVID-19. Dos Santos RAS, Taccone FS, Annoni F. JAMA; 2023 Aug 15; 330(7):663-664. PubMed ID: 37581678 [No Abstract] [Full Text] [Related]
20. Renin-Angiotensin System Modulation in Adults With COVID-19-Reply. Self WH, DeClercq J, Orr M, ACTIV-4 Host Tissue Investigators. JAMA; 2023 Aug 15; 330(7):664-665. PubMed ID: 37581675 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]